Scinai Immunotherapeutics (SCNI) Short-term Investments (2015 - 2026)

Scinai Immunotherapeutics has reported Short-term Investments for 9 years, with the latest figure at $151.0 million in Q1 2026.

• Quarterly Short-term Investments changed N/A year-over-year to $151.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $151.0 million (changed N/A YoY) and the FY2025 annual result came in at $150.0 million, up 114403.82% from the prior year.
• Short-term Investments improved to $151.0 million in Q1 2026 per SCNI's latest filing, from $150.0 million in the prior quarter.
• Over five years, Short-term Investments peaked at $151.0 million in Q1 2026 and troughed at $122000.0 in Q3 2023.
• A 5-year average of $21.6 million and a median of $138000.0 in 2022 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2023 and 2025: Short-term Investments fell 10.29% in 2023, then jumped 114403.82% in 2025.
• Over 5 years, Short-term Investments stood at $140000.0 in 2022, then changed by 0.0% to $140000.0 in 2023, then decreased by 6.43% to $131000.0 in 2024, then surged by 114403.82% to $150.0 million in 2025, then grew by 0.67% to $151.0 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $151.0 million, $150.0 million, and $142000.0 for Q1 2026, Q4 2025, and Q2 2025 respectively.